Compass Pathways Plc (CMPS)
13.24
-0.27
(-2.00%)
USD |
NASDAQ |
Sep 01, 16:00
13.11
-0.13
(-0.98%)
After-Hours: 06:15
Compass Pathways Total Long Term Debt (Quarterly) : 52.74M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.74M |
| March 31, 2026 | 51.26M |
| December 31, 2025 | 32.92M |
| September 30, 2025 | 33.24M |
| June 30, 2025 | 33.24M |
| March 31, 2025 | 30.80M |
| December 31, 2024 | 30.47M |
| September 30, 2024 | 30.25M |
| June 30, 2024 | 30.23M |
| March 31, 2024 | 30.43M |
| December 31, 2023 | 30.64M |
| September 30, 2023 | 30.43M |
| June 30, 2023 | 30.66M |
| Date | Value |
|---|---|
| March 31, 2023 | 0.412M |
| December 31, 2022 | 0.418M |
| September 30, 2022 | 0.425M |
| June 30, 2022 | 0.818M |
| March 31, 2022 | 0.843M |
| December 31, 2021 | 1.379M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Silence Therapeutics Plc | 0.009M |
| Biodexa Pharmaceuticals Plc | 0.00 |
| NuCana Plc | 0.892M |
| Mereo BioPharma Group Plc | 0.00 |
| HemoGenyx Pharmaceuticals Plc | 0.00 |